Founded last year, Mozart Therapeutics lands $55M to develop therapies for celiac and other diseases by Charlotte Schubert on October 26, 2021October 26, 2021 at 12:38 pm A year and a few months since its founding, Mozart Therapeutics has secured $55 million to develop therapies for celiac disease and other immune-related conditions, the company announced Tuesday. The… Read More